Guideline | Drug Name |
---|---|
Trikafta (elexacaftor/tezacaftor/ivacaftor) | Trikafta (elexacaftor/tezacaftor/ivacaftor) |
Trodelvy (sacituzumab govitecan-hziy) | Trodelvy (sacituzumab govitecan-hziy) |
Truqap (capivasertib) | Truqap (capivasertib) |
Truseltiq (infigratinib) | Truseltiq (infigratinib) |
Tryvio (aprocitentan) | Tryvio (aprocitentan) |
Tukysa (tucatinib) | Tukysa (tucatinib) |
Turalio (pexidartinib) | Turalio (pexidartinib) |
Tykerb (lapatinib) | Tykerb (lapatinib) |
Tymlos (abaloparatide injection) | Tymlos (abaloparatide injection) |
Tyrvaya (varenicline solution) | Tyrvaya (varenicline solution) nasal spray |
Tysabri (natalizumab) | Tysabri (natalizumab) |
Tzield (teplizumab - mzwv) - PA, NF | Tzield (teplizumab - mzwv) |
Ultomiris (ravulizumab-cwvz) | Ultomiris (ravulizumab-cwvz) |
Unituxin (dinutuximab) | Unituxin (dinutuximab) |
Uplizna (inebilizumab-cdon) | Uplizna (inebilizumab-cdon) |
Upneeq (oxymetazoline hydrochloride) | Upneeq (oxymetazoline hydrochloride ophthalmic solution) |
Urea Cycle Disorder Agents - PA, NF | Buphenyl (sodium phenylbutyrate), Olpruva (sodium phenylbutyrate), Pheburane (sodium phenylbutyrate), Ravicti (glycerol phenylbutyrate) |
Ustekinumab | Stelara IV (ustekinumab), Wezlana IV (ustekinumab-auub), Stelara SC (ustekinumab), Wezlana SC (ustekinumab-auub) |
Vafseo (vadadustat) - PA, NF | Vafseo (vadadustat) |
Valchlor (mechlorethamine gel) | Valchlor (mechlorethamine gel) |